Assessment of severity and mortality of COVID‐19 with anti‐A1 and anti‐B IgM isohaemagglutinins, a reflection of the innate immune status-Reference-Cited by-同舟云学术

Assessment of severity and mortality of COVID‐19 with anti‐A1 and anti‐B IgM isohaemagglutinins, a reflection of the innate immune status

Published:2021-07-29 Issue:11 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Ozcelik Fatih¹^ORCID,Tanoglu Alpaslan²^ORCID,Guven Bulent Barıs³^ORCID,Keskin Umran⁴^ORCID,Kaplan Mustafa⁵^ORCID

Affiliation:

1. Department of Medical Biochemistry University of Health Sciences TurkeySultan 2. Abdulhamid Han Training and Research Hospital Istanbul Turkey

2. Department of Gastroenterology University of Health Sciences TurkeySancaktepe Şehit Prof Dr Ilhan Varank Training and Research Hospital Istanbul Turkey

3. Department of Anesthesia and Reanimation University of Health Sciences TurkeySultan 2. Abdulhamid Han Training and Research Hospital Istanbul Turkey

4. Department of Internal Medicine University of Health Sciences TurkeyHaydarpasa Numune Training and Research Hospital Istanbul Turkey

5. Department of Internal Medicine University of Health Sciences TurkeySultan 2. Abdulhamid Han Training and Research Hospital Istanbul Turkey

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14624

Reference39 articles.

1. Features Evaluation and Treatment of Coronavirus (COVID‐19)‐ PubMed.https://pubmed.ncbi.nlm.nih.gov/32150360/. Accessed June 19 2021.

2. Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

3. Pathogen Recognition by the Innate Immune System